BACKGROUND: Although the efficacy of carotid endarterectomy for asymptomati
c carotid stenosis has been established, no cost-effective approach for ide
ntification of these patients has yet been devised. The purpose of this stu
dy was to develop a limited carotid duplex screening examination to be util
ized for the detection of asymptomatic carotid stenoses.
METHODS: Carotid screening examinations employed rapid identification of th
e carotid bifurcation using color-flow duplex imaging and an immediate Dopp
ler-derived velocity of the segment of the internal carotid artery with the
most turbulent flow. Complete examinations were then finished using well-e
stablished protocols in our accredited vascular laboratory. A total of 512
patients were referred for complete studies based upon standard indications
. Criteria for at least a 50% internal carotid artery stenosis on the compl
ete examination was defined as a peak systolic velocity (PSV) of at least 1
25 cm/sec. Receiver operator characteristic (ROC) curves were then construc
ted to identify the optimal screening velocity criteria as compared with th
e final results on the complete examination.
RESULTS: Five screening examinations were technically limited yielding a to
tal of 507 patients with 1,014 carotid arteries available for analysis. Com
parison of screening examinations versus complete examinations for a PSV of
125 cm/sec yielded sensitivity 86%, specificity 98%, positive predictive v
alue (PPV) 95%, and a negative predictive value (NPV) 93%, RCC analysis ide
ntified a "cut point" of 115 cm/sec on the screening examinations to achiev
e sensitivity 91%, specificity 95%, PPV 89%, and NPV 96%, Time to perform s
creening examinations averaged 3.2 minutes per patient. Three patients had
common carotid lesions not identified on the limited internal carotid scree
ning examinations.
CONCLUSIONS: Screening carotid examinations are a rapid, reliable, and rela
tively inexpensive method for detection of patients with asymptomatic inter
nal carotid artery stenosis. Limited screening examinations should be devel
oped in each vascular laboratory and utilized in high-risk patients. Am J S
urg. 1999;178:174-177. (C) 1999 by Excerpta Medica, Inc.